Novel peptide inhibitors for the treatment of malignant melanoma
Malignant melanoma is characterized by aggressive local growth and early formation of metastasis. The Melanoma Inhibitory Activity (MIA) protein is known to promote invasion of melanoma cells into healthy tissue and triggers formation of metastases. After determining the functional state of MIA, the inventors of the University of Regensburg (Germany) have identi ed several peptides which inhibit MIA protein functional activity and strongly reduce the formation of metastases in vivo. These inhibitors may offer a novel treatment strategy in preventing or reducing of formation of metastases in malignant melanoma.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Durable, Efficient, Sustainable: The Rise of Cerium Oxide Thermal Switches
Groundbreaking cerium oxide-based thermal switches achieve remarkable performance, transforming heat flow control with sustainable and efficient technology. Cerium Oxide-Based Thermal Switches Revolutionize Heat Flow Control Thermal switches, which electrically control…
How Industrial Robots are Reducing Emissions in Global Manufacturing
A new study explores the intersection of industrial automation and environmental sustainability, focusing on the role of industrial robots in reducing the carbon intensity of manufacturing exports. The research demonstrates…
Patients Can Heal Through Precise, Personalized Bioceramic Grafts
A recent review is transforming the landscape of craniomaxillofacial bone regeneration with the introduction of personalized bioceramic grafts. This pioneering research explores the fabrication and clinical potential of synthetic grafts…